Scaling Innovative Clinical Trial Approaches: Challenges, Progress, and Opportunities
Hybrid Event
This hybrid workshop, co-convened by the Duke-Margolis Institute for Health Policy and the U.S. Food and Drug Administration (FDA) CDER Center for Clinical Trial Innovation (C3TI), will explore progress in clinical trial innovation to improve the efficiency of drug development. The meeting will highlight C3TI’s activities, including the C3TI Demonstration Program, and emerging priorities. Sessions […]
Free